Cornell Research Foundation Inc.

Cornell University

Novasterilis, Inc.

Bruce Ganem

Michael K Tong

George Papandreou

Anthony Romey Eisenhut

David C Burns

Donald J Creighton

Diana S Hamilton

Martha A Mutschler

Timothy Wayne Christensen

Angela Lydia White

Zhebo Ding

Described herein are new enone derivatives and conjugates. Additionally, methods for synthesizing these new enones are also disclosed. These compounds can be employed in cancer therapy.

Enone cancer therapeutics

Sterilization methods and apparatus are effective to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores, i.e.,andspores, by subjecting sterilizable materials to a chemical additive-containing carbon dioxide sterilant fluid at or near its supercritical pressure and temperature conditions. Most preferably, the chemical additive-containing supercritical carbon dioxide sterilant fluid is agitated during sterilization, e.g., via mechanical agitation or via pressure cycling.

Sterialization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant

Broad spectrum glycosidase inhibitors are produced from monosaccharide lactams by conversion to amidines, amidrazones or amidoximes. The inhibitors have the general formula: ##STR1## wherein the N and C are joined as part of a monosaccharide azaanalog ring and wherein --NRQ, together with the nitrogen and carbon atoms, form a chemical group selected from amidines, amidrazones, and amidoximes.

Monosaccharide analog-based glycosidase inhbitors

A method for repelling insects from plants with non-cyclic esters is disclosed. The esters are prepared from a non-cyclic polyhydroxyl compound having from about 3 to about 5 carbon atoms and at least three hydroxyl groups and a carboxylic acid. In the esters at least two of the hydroxyl groups are esterified and the total number of carbon atoms in all of the ester groups is from about 9 to about 19.

Non-cyclic esters for pest control

Broad spectrum glycosidase inhibitors are produced from monosaccharide lactams by conversion to amidines, amidrazones, or amidoximes. The inhibitors have the general formula: ##STR1## wherein the N and C are joined as part of a monosaccharide azaanalog ring and wherein --NRQ, together with the nitrogen and carbon atoms, form a chemical group selected from amidines, amidrazones, and amidoximes.

Growing community of inventors

Ithaca, NY, United States of America

Bruce Ganem